Cardlytics Stock Today
| CDLX Stock | USD 2.35 0.00 0.00% |
PerformanceVery Weak
| Odds Of DistressQuite High
|
Cardlytics is trading at 2.35 as of the 17th of March 2025; that is No Change since the beginning of the trading day. The stock's open price was 2.345. Cardlytics has more than 66 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Business Domain Media & Entertainment | IPO Date 9th of February 2018 | Category Communication Services |
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia. Cardlytics operates under Advertising Agencies classification in the United States and is traded on NASDAQ Exchange. The company has 52.09 M outstanding shares of which 8.33 M shares are currently shorted by private and institutional investors with about 10.59 trading days to cover. More on Cardlytics
Moving together with Cardlytics Stock
Moving against Cardlytics Stock
Cardlytics Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO Director | Amit Gupta | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Advertising, Media & Entertainment, Communication Services, Nasdaq Benchmark Consumer, NASDAQ Composite, Communication Services, Media, Advertising Agencies, Communication Services (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsCardlytics can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Cardlytics' financial leverage. It provides some insight into what part of Cardlytics' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cardlytics (CDLX) is traded on NASDAQ Exchange in USA. It is located in 675 Ponce de Leon Avenue NE, Atlanta, GA, United States, 30308 and employs 454 people. Cardlytics is listed under Advertising category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 128.65 M. Cardlytics conducts business under Media sector and is part of Communication Services industry. The entity has 52.09 M outstanding shares of which 8.33 M shares are currently shorted by private and institutional investors with about 10.59 trading days to cover.
Cardlytics currently holds about 157.04 M in cash with (8.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Cardlytics Probability Of Bankruptcy
Ownership AllocationCardlytics holds a total of 52.09 Million outstanding shares. Over half of Cardlytics' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cardlytics Ownership Details
Cardlytics Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Dimensional Fund Advisors, Inc. | 2024-12-31 | 498.1 K | |
| Citigroup Inc | 2024-12-31 | 477.3 K | |
| Ubs O'connor Llc | 2024-12-31 | 450 K | |
| Renaissance Technologies Corp | 2024-12-31 | 403.4 K | |
| Charles Schwab Investment Management Inc | 2024-12-31 | 402.6 K | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 389.8 K | |
| Northern Trust Corp | 2024-12-31 | 373.8 K | |
| Landscape Capital Management,llc | 2024-12-31 | 339.2 K | |
| Pb Investment Partners, L.p. | 2024-12-31 | 338.2 K | |
| Blackrock Inc | 2024-12-31 | 3.2 M | |
| Vanguard Group Inc | 2024-12-31 | 2.7 M |
Cardlytics Historical Income Statement
Cardlytics Stock Against Markets
Cardlytics Corporate Management
| Evelyne Forester | Chief Officer | Profile | |
| Carson Napps | Chief Officer | Profile | |
| Jose Singer | Chief Officer | Profile | |
| Alexis DeSieno | Chief Officer | Profile | |
| Karim Temsamani | CEO Director | Profile | |
| James Hart | VP People | Profile |
Additional Tools for Cardlytics Stock Analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.